AI Article Synopsis
- The study explored how adding alkylamines or benzylamine to a non-aqueous vehicle could enhance the skin permeability of salicylate in guinea pig skin.
- It was found that longer alkyl chains in amines significantly increased salicylate's solubility and flux, with n-hexylamine resulting in an 11-fold increase in flux.
- Additionally, the combination of benzylamine with ethanol and menthol further boosted solubility and permeability, indicating a potential method to improve topical drug delivery.
Article Abstract
Enhancement of skin permeability of salicylate from non-aqueous vehicle by ion-pair formation with either alkylamines or benzylamine as model cationic ions was examined in excised guinea pig dorsal skin. Solubility of salicylate in isopropyl myristate (IPM) was increased by the addition of either alkylamines or benzylamine as counter ions. The increase was more significant in the presence of amines with longer alkyl chains. Flux of salicylate increased in the presence of these amines due to the increase in the solubility. Maximum flux was observed in the presence of n-hexylamine, which induced an 11-fold increase due to 137-fold increase in solubility. Flux and permeability coefficients of salicylate in the presence of n-butylamine, n-hexylamine, iso-octylamine and benzylamine as counter ions in IPM were larger than those of the non-ionic form of salicylic acid. Flux of 3-methylsalicylate (3-CH3 substituent) and that of 5-hydroxysalicylate (5-OH substituent) were smaller than that of salicylate in the presence of n-hexylamine. After partition to the skin surface, the ion-pair is suggested to dissociate and permeate separately according to the study using lidocaine as the counter ion. Flux of salicylate increased in the presence of benzylamine as the counter ion by the addition of 15% ethanol and 15% ethanol plus 1% l-menthol due to further improvement in the solubility as well as an increase in the permeability coefficient.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1248/cpb.54.481 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Polypharmacology of ambroxol in the treatment of COVID-19.
Biosci Rep
February 2023
Department of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, China.
The pandemic of coronavirus disease 2019 (COVID-19) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still underway. Due to the growing development of severe symptoms, it is necessary to promote effective therapies. Ambroxol [2-amino-3,5-dibromo-N-(trans-4-hydroxycyclohexyl) benzylamine] has long been used as one of the over-the-counter mucolytic agents to treat various respiratory diseases.
View Article and Find Full Text PDFAn overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children.
Multidiscip Respir Med
January 2020
Global Medical Lead CHC, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.
Ambroxol (2-amino-3,5-dibromo-N-[trans-4-hydroxycyclohexyl]benzylamine), an over-the-counter product, is a mucoactive agent and has been used widely to treat both acute and chronic respiratory diseases since 1978. This review aims to provide an overview of the clinical evidence available on the use of ambroxol in children with acute and chronic respiratory diseases. Data for this review were obtained from both published and unpublished clinical studies, and real-world evidence studies.
View Article and Find Full Text PDFCXCR4-targeted PET imaging using Cu-AMD3100 for detection of Waldenström Macroglobulinemia.
Cancer Biol Ther
March 2021
Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
: Waldenström Macroglobulinemia (WM) is a rare B-cell malignancy characterized by secretion of immunoglobulin M and cancer infiltration in the bone marrow. Chemokine receptor such as CXCR4 and hypoxic condition in the bone marrow play crucial roles in cancer cell trafficking, homing, adhesion, proliferation, survival, and drug resistance. Herein, we aimed to use CXCR4 as a potential biomarker to detect hypoxic-metastatic WM cells in the bone marrow and in the circulation by using CXCR4-detecting radiopharmaceutical.
View Article and Find Full Text PDFIon Separation in Air Using a Three-Dimensional Printed Ion Mobility Spectrometer.
Anal Chem
May 2017
Chemistry Department, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.
The performance of a small, plastic drift tube ion mobility spectrometer (DT-IMS) is described. The IMS was manufactured using three-dimensional (3D) printing techniques and operates in the open air at ambient pressure, temperature, and humidity. The IMS housing and electrodes were printed from nonconductive polylactic acid (PLA, housing) and conductive polyethylene terephthalate glycol-modified polymer containing multiwalled carbon nanotubes (PETG-CNT, electrodes).
View Article and Find Full Text PDFClinical Pharmacokinetics and Pharmacodynamics of Safinamide.
Clin Pharmacokinet
March 2017
Department of Neurology, St. Joseph Hospital Berlin-Weißensee, Gartenstr. 1, 13088, Berlin, Germany.
The symptoms of Parkinson's disease (PD) reflect disruptions of a number of brain neurotransmitter systems of varying type and degree. Pharmacological agents with multiple neurochemical mechanisms of action are therefore promising candidates for countering these problems and providing comprehensive symptomatic relief for patients. The pharmacological profile of safinamide includes reversible monoamine oxidase B inhibition, blockage of voltage-dependent Na channels, modulation of Ca channels, and inhibition of glutamate release.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!